Table 1.
Characteristic | Total Sample (N=42) | |
---|---|---|
n | % | |
Patient age, M (SD) | 44.21 (9.0) | |
Months since metastatic diagnosis, M (SD) | 17.12 (17.77) | |
Number of children <18, M (SD) | 2.23 (1.01) | |
Age of children, M (SD) | 11.56 (4.08) | |
Patient education (years), M (SD) | 15.76 (3.6) | |
Patient gender | ||
Male | 15 | 35.71 |
Female | 27 | 64.29 |
Race/Ethnicity | ||
White, non-Hispanic | 31 | 73.81 |
Black, non-Hispanic | 7 | 16.67 |
Other | 4 | 9.52 |
Marital status | ||
Partnered/married | 29 | 69.05 |
Single | 13 | 30.95 |
Income | ||
< $25,000 | 12 | 29.27 |
$25–50,000 | 9 | 21.95 |
$50–100,000 | 13 | 31.71 |
> $100,000 | 7 | 7.07 |
Metastatic at diagnosis | 22 | 52.38 |
Cancer site | ||
Breast | 10 | 23.81 |
Melanoma | 7 | 16.67 |
Colon | 6 | 14.29 |
Other | 19 | 45.24 |
ECOG1 Status | ||
High (0–1) | 25 | 59.52 |
Low (2–4) | 17 | 40.48 |
Receiving anti-neoplastic treatment at time of interview | 36 | 85.71 |
ECOG = Eastern Cooperative Oncology Group Performance Status Scale